Skip to main content
PMC home page
Heart logoLink to Heart
. 1999 Sep;82(3):319–324. doi: 10.1136/hrt.82.3.319

Incidence and modes of onset of early reinitiation of atrial fibrillation after successful internal cardioversion, and its prevention by intravenous sotalol

H Tse 1, C Lau 1, G Ayers 1
PMCID: PMC1729161  PMID: 10455082

Abstract

OBJECTIVES—To study the incidence and mode of onset of early reinitiation of atrial fibrillation (ERAF) following successful internal cardioversion of chronic atrial fibrillation, and to determine the effects of sotalol in the prevention of ERAF.
DESIGN—The incidence and modes of onset of ERAF and the acute effects of intravenous sotalol in the prevention of ERAF were studied retrospectively.
SETTING—Electrophysiology laboratory at a university teaching hospital.
PATIENTS—64 patients, mean (SD) age 62 (10) years, who underwent internal cardioversion of chronic atrial fibrillation (mean duration of atrial fibrillation 31 (39) months).
MAIN OUTCOME MEASURES—ECGs and intracardiac electrograms recorded during the internal cardioversion of atrial fibrillation using 3/3 ms biphasic, R wave synchronised shocks.
RESULTS—52 patients (81%) had successful electrical cardioversion, and 20 (31%) of these had ERAF during the procedure. There was no clinical predictor for the occurrence of ERAF. Fifty eight episodes of ERAF were observed. Five ERAF episodes (9%) had preceding bradycardia and 53 (91%) of these were triggered by atrial premature beats with normal preceding heart rate. Atrial premature beats that reinitiated atrial fibrillation had a shorter coupling interval (333 (43) ms v 396 (100), p < 0.001) and a lower prematurity index (0.44 (0.11) v 0.55 (0.14), p < 0.001) than those that did not reinitiate atrial fibrillation. Repeated shock delivery and increasing the defibrillation energy did not prevent ERAF. Intravenous sotalol infusion decreased the numbers of atrial premature beats and prolonged their coupling interval, and prevented ERAF after repeated defibrillation in 83% of patients with ERAF.
CONCLUSIONS—ERAF is a significant clinical problem after successful internal cardioversion of chronic atrial fibrillation, and was observed in up to 31% of patients. In most episodes, ERAF was triggered by short coupling atrial premature beats with preceding normal heart rate. Intravenous sotalol was effective in preventing ERAF in most cases.


Keywords: atrial fibrillation; low energy cardioversion; sotalol

Full Text

The Full Text of this article is available as a PDF (120.3 KB).

Figure 1  .

Figure 1  

Open in a new tab

Flow chart showing the outcome of patients after low energy internal cardioversion of atrial fibrillation (AF) and the results of treatment for spontaneous reinitiation of atrial fibrillation by repeated defibrillation, intravenous sotalol and atropine, and atrial pacing. SR, sinus rhythm.

Figure 2  .

Figure 2  

Open in a new tab

Different modes of onset of early reinitiation of atrial fibrillation (AF). (A) AF reinitiation preceding by bradycardia (mean atrial cycle length = 1240 ms). (B) AF was reinitiated an atrial premature beat (APB) after a short period of organised electrical activity. Note the normal heart rate preceding the onset of APB. (C) AF was reinitiated by APB with preceding long/short cycles. HRA, high right atrium.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alt E., Schmitt C., Ammer R., Coenen M., Fotuhi P., Karch M., Blasini R. Initial experience with intracardiac atrial defibrillation in patients with chronic atrial fibrillation. Pacing Clin Electrophysiol. 1994 May;17(5 Pt 2):1067–1078. doi: 10.1111/j.1540-8159.1994.tb01462.x. [DOI] [PubMed] [Google Scholar]
  2. Attuel P., Pellerin D., Mugica J., Coumel P. DDD pacing: an effective treatment modality for recurrent atrial arrhythmias. Pacing Clin Electrophysiol. 1988 Nov;11(11 Pt 2):1647–1654. doi: 10.1111/j.1540-8159.1988.tb06289.x. [DOI] [PubMed] [Google Scholar]
  3. Bennett M. A., Pentecost B. L. The pattern of onset and spontaneous cessation of atrial fibrillation in man. Circulation. 1970 Jun;41(6):981–988. doi: 10.1161/01.cir.41.6.981. [DOI] [PubMed] [Google Scholar]
  4. Bianconi L., Mennuni M., Lukic V., Castro A., Chieffi M., Santini M. Effects of oral propafenone administration before electrical cardioversion of chronic atrial fibrillation: a placebo-controlled study. J Am Coll Cardiol. 1996 Sep;28(3):700–706. doi: 10.1016/0735-1097(96)00230-6. [DOI] [PubMed] [Google Scholar]
  5. Capucci A., Santarelli A., Boriani G., Magnani B. Atrial premature beats coupling interval determines lone paroxysmal atrial fibrillation onset. Int J Cardiol. 1992 Jul;36(1):87–93. doi: 10.1016/0167-5273(92)90112-g. [DOI] [PubMed] [Google Scholar]
  6. Daoud E. G., Bogun F., Goyal R., Harvey M., Man K. C., Strickberger S. A., Morady F. Effect of atrial fibrillation on atrial refractoriness in humans. Circulation. 1996 Oct 1;94(7):1600–1606. doi: 10.1161/01.cir.94.7.1600. [DOI] [PubMed] [Google Scholar]
  7. Denker S., Lehmann M. H., Mahmud R., Gilbert C., Akhtar M. Facilitation of macroreentry within the His-Purkinje system with abrupt changes in cycle length. Circulation. 1984 Jan;69(1):26–32. doi: 10.1161/01.cir.69.1.26. [DOI] [PubMed] [Google Scholar]
  8. Jaïs P., Haïssaguerre M., Shah D. C., Chouairi S., Gencel L., Hocini M., Clémenty J. A focal source of atrial fibrillation treated by discrete radiofrequency ablation. Circulation. 1997 Feb 4;95(3):572–576. doi: 10.1161/01.cir.95.3.572. [DOI] [PubMed] [Google Scholar]
  9. Kay G. N., Plumb V. J., Arciniegas J. G., Henthorn R. W., Waldo A. L. Torsade de pointes: the long-short initiating sequence and other clinical features: observations in 32 patients. J Am Coll Cardiol. 1983 Nov;2(5):806–817. doi: 10.1016/s0735-1097(83)80226-5. [DOI] [PubMed] [Google Scholar]
  10. Kennedy R. J., Killip T. The onset of atrial fibrillation in man. Am Heart J. 1971 Sep;82(3):429–431. doi: 10.1016/0002-8703(71)90314-0. [DOI] [PubMed] [Google Scholar]
  11. Kumagai K., Yamanouchi Y., Hiroki T., Arakawa K. Effects of transcatheter cardioversion on chronic lone atrial fibrillation. Pacing Clin Electrophysiol. 1991 Nov;14(11 Pt 1):1571–1575. doi: 10.1111/j.1540-8159.1991.tb02730.x. [DOI] [PubMed] [Google Scholar]
  12. Lau C. P., Tse H. F., Ayers G. M. Defibrillation-guided radiofrequency ablation of atrial fibrillation secondary to an atrial focus. J Am Coll Cardiol. 1999 Apr;33(5):1217–1226. doi: 10.1016/s0735-1097(98)00691-3. [DOI] [PubMed] [Google Scholar]
  13. Lok N. S., Lau C. P., Ho D. S., Tang Y. W. Hemodynamic effects and clinical determinants of defibrillation threshold for transvenous atrial defibrillation using biatrial biphasic shocks in patients with chronic atrial fibrillation. Pacing Clin Electrophysiol. 1997 Apr;20(4 Pt 1):899–908. doi: 10.1111/j.1540-8159.1997.tb05492.x. [DOI] [PubMed] [Google Scholar]
  14. Lown B. Electrical reversion of cardiac arrhythmias. Br Heart J. 1967 Jul;29(4):469–489. doi: 10.1136/hrt.29.4.469. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Lévy S., Lauribe P., Dolla E., Kou W., Kadish A., Calkins H., Pagannelli F., Moyal C., Bremondy M., Schork A. A randomized comparison of external and internal cardioversion of chronic atrial fibrillation. Circulation. 1992 Nov;86(5):1415–1420. doi: 10.1161/01.cir.86.5.1415. [DOI] [PubMed] [Google Scholar]
  16. Lévy S., Ricard P., Gueunoun M., Yapo F., Trigano J., Mansouri C., Paganelli F. Low-energy cardioversion of spontaneous atrial fibrillation. Immediate and long-term results. Circulation. 1997 Jul 1;96(1):253–259. doi: 10.1161/01.cir.96.1.253. [DOI] [PubMed] [Google Scholar]
  17. Lévy S., Ricard P., Lau C. P., Lok N. S., Camm A. J., Murgatroyd F. D., Jordaens L. J., Kappenberger L. J., Brugada P., Ripley K. L. Multicenter low energy transvenous atrial defibrillation (XAD) trial results in different subsets of atrial fibrillation. J Am Coll Cardiol. 1997 Mar 15;29(4):750–755. doi: 10.1016/s0735-1097(96)00583-9. [DOI] [PubMed] [Google Scholar]
  18. Murgatroyd F. D., Slade A. K., Sopher S. M., Rowland E., Ward D. E., Camm A. J. Efficacy and tolerability of transvenous low energy cardioversion of paroxysmal atrial fibrillation in humans. J Am Coll Cardiol. 1995 May;25(6):1347–1353. doi: 10.1016/0735-1097(94)00555-5. [DOI] [PubMed] [Google Scholar]
  19. Schmitt C., Alt E., Plewan A., Ammer R., Leibig M., Karch M., Schömig A. Low energy intracardiac cardioversion after failed conventional external cardioversion of atrial fibrillation. J Am Coll Cardiol. 1996 Oct;28(4):994–999. doi: 10.1016/s0735-1097(96)00274-4. [DOI] [PubMed] [Google Scholar]
  20. Sra J., Biehl M., Blanck Z., Dhala A., Jazayeri M. R., Deshpande S., Akhtar M. Spontaneous reinitiation of atrial fibrillation following transvenous atrial defibrillation. Pacing Clin Electrophysiol. 1998 May;21(5):1105–1110. doi: 10.1111/j.1540-8159.1998.tb00157.x. [DOI] [PubMed] [Google Scholar]
  21. Strickberger S. A., Man K. C., Daoud E. G., Goyal R., Brinkman K., Knight B. P., Weiss R., Bahu M., Morady F. Adenosine-induced atrial arrhythmia: a prospective analysis. Ann Intern Med. 1997 Sep 15;127(6):417–422. doi: 10.7326/0003-4819-127-6-199709150-00001. [DOI] [PubMed] [Google Scholar]
  22. Timmermans C., Rodriguez L. M., Smeets J. L., Wellens H. J. Immediate reinitiation of atrial fibrillation following internal atrial defibrillation. J Cardiovasc Electrophysiol. 1998 Feb;9(2):122–128. doi: 10.1111/j.1540-8167.1998.tb00893.x. [DOI] [PubMed] [Google Scholar]
  23. Wellens H. J., Lau C. P., Lüderitz B., Akhtar M., Waldo A. L., Camm A. J., Timmermans C., Tse H. F., Jung W., Jordaens L. Atrioverter: an implantable device for the treatment of atrial fibrillation. Circulation. 1998 Oct 20;98(16):1651–1656. doi: 10.1161/01.cir.98.16.1651. [DOI] [PubMed] [Google Scholar]

Articles from Heart are provided here courtesy of BMJ Publishing Group

RESOURCES